{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:28:51Z","timestamp":1787016531992,"version":"build-2736575974"},"reference-count":51,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AI170426"],"award-info":[{"award-number":["U01AI170426"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["AI068632"],"award-info":[{"award-number":["AI068632"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011725","name":"Meningitis Now","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Adult Clinical Trial Group"},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024310","name":"Wellcome Centre for Infectious Diseases Research in Africa","doi-asserted-by":"crossref","award":["203135\/Z\/16\/Z"],"award-info":[{"award-number":["203135\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/501100024310","id-type":"DOI","asserted-by":"crossref"}]},{"name":"UCL Wellcome Trust PhD Programme for Clinicians Fellowship","award":["175479"],"award-info":[{"award-number":["175479"]}]},{"DOI":"10.13039\/501100024310","name":"Wellcome Centre for Infectious Diseases Research in Africa","doi-asserted-by":"crossref","award":["CC2112"],"award-info":[{"award-number":["CC2112"]}],"id":[{"id":"10.13039\/501100024310","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["CC2112"],"award-info":[{"award-number":["CC2112"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["CC2112"],"award-info":[{"award-number":["CC2112"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01145436"],"award-info":[{"award-number":["R01145436"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI068634, UM1 AI068636, UM1 AI106701"],"award-info":[{"award-number":["UM1 AI068634, UM1 AI068636, UM1 AI106701"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01 AI068632"],"award-info":[{"award-number":["U01 AI068632"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2025,8,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Pyrazinamide and isoniazid are first-line drugs for tuberculous meningitis (TBM), but limited information is available on their plasma pharmacokinetics, and particularly cerebrospinal fluid (CSF) penetration, in patients with TBM. Any potential effect of co-administration with high-dose rifampicin, also being evaluated in trials for TBM, is unknown. Understanding this is important for dose optimisation. We characterized pyrazinamide and isoniazid plasma and CSF pharmacokinetics among adults enrolled in a phase 2 clinical trial of intensified antibiotic therapy for HIV-associated TBM. Participants were randomized to receive either standard TBM treatment (including rifampicin 10 mg\/kg) or high-dose rifampicin (35 mg\/kg) plus linezolid, with or without aspirin. Plasma and lumbar CSF samples were collected on days 3 and 28 after study enrollment, and drug concentrations were measured using liquid chromatography-tandem mass spectrometry. Data were analysed using nonlinear mixed-effects modeling. Forty-nine participants provided 414 plasma and 44 CSF concentrations. Pyrazinamide CSF concentrations equilibrated with plasma with a half-life of 0.66 h and a pseudo-partition coefficient of 1.05. Isoniazid concentrations equilibrated with a half-life of 3.87 h and a pseudo-partition coefficient of 1.04. Pyrazinamide clearance increased by 30% from day 3 to day 28. NAT2 phenotype determined multi-modal isoniazid clearance. High-dose rifampicin did not affect pyrazinamide or isoniazid plasma pharmacokinetics or CSF penetration. Both drugs achieved exposure in CSF similar to plasma, supporting their crucial role in TBM treatment. Plasma pharmacokinetics of pyrazinamide and isoniazid in TBM were consistent with previously reported values in pulmonary tuberculosis, even when co-administered with high-dose rifampicin.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/aac.00099-25","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:56:37Z","timestamp":1751363797000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":4,"title":["Population pharmacokinetics of pyrazinamide and isoniazid in plasma and cerebrospinal fluid from South African adults with tuberculous meningitis"],"prefix":"10.1128","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0310-6949","authenticated-orcid":true,"given":"Jose M.","family":"Calderin","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03p74gp79","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town","place":["Cape Town, Republic of South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3508-6719","authenticated-orcid":true,"given":"Sean","family":"Wasserman","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03p74gp79","id-type":"ROR","asserted-by":"publisher"}],"name":"Wellcome Discovery Research Platforms in Infection, Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town","place":["Cape Town, Republic of South Africa"]},{"id":[{"id":"https:\/\/ror.org\/040f08y74","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute for Infection and Immunity, City St George\u2019s, University of London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9111-8052","authenticated-orcid":true,"given":"Juan Eduardo","family":"Resendiz-Galvan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03p74gp79","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town","place":["Cape Town, Republic of South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4907-345X","authenticated-orcid":true,"given":"Noha","family":"Abdelgawad","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03p74gp79","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town","place":["Cape Town, Republic of South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angharad","family":"Davis","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03p74gp79","id-type":"ROR","asserted-by":"publisher"}],"name":"Wellcome Discovery Research Platforms in Infection, Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town","place":["Cape Town, Republic of South Africa"]},{"id":[{"id":"https:\/\/ror.org\/04tnbqb63","id-type":"ROR","asserted-by":"publisher"}],"name":"The Francis Crick Institute","place":["London, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/02jx3x895","id-type":"ROR","asserted-by":"publisher"}],"name":"Faculty of Life Sciences, University College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cari","family":"Stek","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03p74gp79","id-type":"ROR","asserted-by":"publisher"}],"name":"Wellcome Discovery Research Platforms in Infection, Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town","place":["Cape Town, Republic of South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9070-8699","authenticated-orcid":true,"given":"Lubbe","family":"Wiesner","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03p74gp79","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town","place":["Cape Town, Republic of South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Wilkinson","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03p74gp79","id-type":"ROR","asserted-by":"publisher"}],"name":"Wellcome Discovery Research Platforms in Infection, Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town","place":["Cape Town, Republic of South Africa"]},{"id":[{"id":"https:\/\/ror.org\/04tnbqb63","id-type":"ROR","asserted-by":"publisher"}],"name":"The Francis Crick Institute","place":["London, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/03p74gp79","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town","place":["Cape Town, Republic of South Africa"]},{"id":[{"id":"https:\/\/ror.org\/041kmwe10","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Infectious Diseases, Imperial College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7494-079X","authenticated-orcid":true,"given":"Paolo","family":"Denti","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03p74gp79","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town","place":["Cape Town, Republic of South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2019.1638912"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11121843"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-018-0490-9"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126436"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.MGM2-0023-2013"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141002"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1470-x"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2020-321426"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00487-20"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.06.010"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2020.06.007"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19138125"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.049452"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.15565.2"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab162"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac932"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00140-21"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000062"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01059688"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00641-18"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1979253358"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544100-00004"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.48.113006.094708"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2044"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-012-9373-2"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/psp.2013.14"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1023\/a:1012299115260"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-017-9542-0"},{"key":"e_1_3_4_31_2","volume-title":"Statistical adjustment of data","author":"Deming E","year":"1946","unstructured":"Deming E. 1946. Statistical adjustment of data. Wiley, Oxford."},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkac188"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00490-17"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.3390\/ph13110394"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13091479"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00512-18"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1177\/1179573517693802"},{"key":"e_1_3_4_38_2","first-page":"45","volume-title":"Advances in pharmacology","author":"Ashraf T","year":"2014","unstructured":"Ashraf T, Kao A, Bendayan R. 2014. Chapter three - Functional expression of drug transporters in glial cells: potential role on drug delivery to the CNS, p 45\u2013111. In Davis TP (ed), Advances in pharmacology. Academic Press."},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S401281"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1783"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.1990.5.1.39"},{"key":"e_1_3_4_42_2","unstructured":"WHO. 2018. Technical report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis. Geneva World Health Organization WHO\/CDS\/TB\/2018.5. https:\/\/iris.who.int\/bitstream\/handle\/10665\/260470\/WHO-CDS-TB-2018.5-eng.pdf?sequence=1."},{"key":"e_1_3_4_43_2","unstructured":"WHO. 2021. Technical report on critical concentrations for drug susceptibility testing of isoniazid and the rifamycins (rifampicin rifabutin and rifapentine). Geneva World Health Organization. https:\/\/iris.who.int\/bitstream\/handle\/10665\/339275\/9789240017283-eng.pdf?sequence=1."},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00003-22"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02625-16"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02599-12"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02013-2020"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-0711-5-3"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342090-00003"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03189884"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1086\/599040"},{"key":"e_1_3_4_52_2","unstructured":"Werely C. 2012. Pharmacogenetics of arylamine N-acetyltransferase genes in South African populations. Stellenbosch University."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00099-25","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00099-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T21:38:57Z","timestamp":1773178737000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.00099-25"}},"subtitle":[],"editor":[{"given":"Sarah","family":"Doernberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,6]]}},"alternative-id":["10.1128\/aac.00099-25"],"URL":"https:\/\/doi.org\/10.1128\/aac.00099-25","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"2025-01-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00099-25"}}